Viewing Study NCT00210366


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-02-20 @ 6:38 PM
Study NCT ID: NCT00210366
Status: TERMINATED
Last Update Posted: 2010-07-30
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-11
Start Date Type: None
Primary Completion Date: 2010-07
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-09-13
First Submit QC Date: None
Study First Post Date: 2005-09-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-07-29
Last Update Post Date: 2010-07-30
Last Update Post Date Type: ESTIMATED